Search filters

List of works by Josep Maria Gatell

A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study

scientific article published in 2002

A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.

scientific article

A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication

scientific article published in January 2013

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

scientific article published in July 2009

A therapeutic dendritic cell-based vaccine for HIV-1 infection

scientific article published on 13 January 2011

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study

scientific article

CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use.

scientific article published in March 2013

Causes of death in HIV infection

article

Chronic renal failure among HIV-1-infected patients

scientific article published in May 2007

Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study).

scientific article published in April 2004

Correction: Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

scientific article

Deteriorating renal function and clinical outcomes in HIV-positive persons

scientific article

Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals

scientific article

Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: a randomized clinical trial

scientific article published on 10 November 2014

Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial

scientific article published on 01 July 2018

Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals

scientific article published on 27 January 2014

El papel de las combinaciones de antirretrovirales a dosis fijas en el tratamiento de la infección por VIH-1

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

scientific article published in July 2010

Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).

scientific article published on 25 May 2015

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2014).

scientific article published on 28 June 2014

Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study)

scientific article

HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses

scientific article

High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients).

scientific article

Immunological function restoration with lopinavir/ritonavir versus efavirenz containing regimens in HIV-infected patients: a randomized clinical trial

scientific article published on 10 February 2014

Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients

scientific article published on 19 September 2007

Impact of switching from lopinavir/ritonavir to atazanavir/ritonavir on body fat redistribution in virologically suppressed HIV-infected adults

scientific article published on 15 January 2011

Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

scientific article published on 01 December 2005

LDL subclasses and lipoprotein-phospholipase A2 activity in suppressed HIV-infected patients switching to raltegravir: Spiral substudy

scientific article published on 6 September 2012

Long-term exposure to combination antiretroviral therapy and risk of death from specific causes ⬇️

article by Justyna D. Kowalska et al published January 2012 in AIDS

Low-density lipoprotein size and lipoprotein-associated phospholipase A2 in HIV-infected patients switching to abacavir or tenofovir

scientific article published in January 2011

Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe

scientific article published on June 2006

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

scientific article published on August 2009

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen

scientific article

Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.

scientific article published in January 2007

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection

scientific article

Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).

scientific article published on 09 September 2011

Safety and immunogenicity of a modified vaccinia Ankara-based HIV-1 vaccine (MVA-B) in HIV-1-infected patients alone or in combination with a drug to reactivate latent HIV-1.

scientific article published on 26 February 2015

Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.

scientific article published on 24 October 2017

Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS

scientific article published on 9 June 2010

Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

article

Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)

scientific article published in December 2004

Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection

scientific article published in September 2003

Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment

scientific article published on April 2007

The Clinical Benefits of Antiretroviral Therapy in Severely Immunocompromised HIV-1-Infected Patients with and without Complete Viral Suppression ⬇️

scientific article published on September 26, 2012

The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens.

scientific article published on 24 August 2011

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe

scientific article published on 2 November 2014

Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients

article

Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals

article

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

article

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

article

Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?

scientific article published on 3 November 2017

Paulina is supported by:

About Paulina

Help